Ispecimen inc. announces $21 million private placement

Lexington, mass., nov. 29, 2021 /prnewswire/ -- ispecimen inc. (nasdaq: ispc) ("ispecimen" or the "company"), an online marketplace for human biospecimens, today announced that it has entered into a definitive securities purchase agreement for a private placement with three accredited investors for the sale of 1,749,999 shares of common stock of ispecimen together with warrants to purchase 1,312,500 shares of common stock ("warrants"), which will result in gross proceeds to ispecimen of approximately $21.0 million, before deducting placement offering expenses.
ISPC Ratings Summary
ISPC Quant Ranking